bg.png
hat2.png
hat3.png

Demo Day 2020

logo banner.png
logo.png
hat1.png
8.png
3.png
4.png
1.png
6.png
5.png
2.png
9.png
Picture1.png

Hillary Harel

CEO

8.png

Innovative decision support tools for health service industry increasing quality of care and saving valuable resources.

 

Read more...


Serenus.AI is an AI-based innovative decision support tool for personalized medical treatment decisions, providing the right treatment, to the right patient at the right time. Major attributions:

  • AI-based objective personalized decision-making.
  • Comprehensive review of all relevant factors and its impact.
  • Alternative conservative recommendations.
  • Improved patient history and data flow.
  • Advanced dashboard and powerful AI-driven analytics





Picture2.png

Dan Berachowitz

CTO

Picture3.png

Prof. Joesf Elidan

CMO

Highlights

Top clinical and AI/ML Experts

 

Multiple signed paid pilots and growing pipeline of clients and distribution partners

 

Patent claims have been registered

 

Awarded and Granted by four government entities including the Bilateral Bird Grant

Winner of Department for International Trade (DIT’s) first-ever "2020 European Women in Tech" 

Named Top AI startup company in "Healthcare Innovation Landscape 2020" Data Roots Labs report

1st Place Winner of MTL Tech Awards 2020 by Printemps numérique and Deloitte OVHcloud

Company Overview

 
amir.png

Amir Elhasid

VP BD

3.png

Low medication adherence, a major cause of poor outcomes and increased costs, is hard to recognize and manage. TimeStamp’s pioneering approach enables the incorporation of IoT into medication providing adherence data into everyday healthcare systems. 

 

Read more...


TimeStamp is adding connectivity & IoT functionality to existing drug-delivery device and packages by applying our proprietary "Smart-Sticker" devices. This pioneering approach enables the incorporation of medication adherence data into everyday healthcare. Unlike competing technologies, TimeStamp’s technology, does not depend on patient engagement.





david.png

Prof. David Price

CMO

gad.png

Gad Riesenfeld

CEO

Highlights

Completed the development of first engineering model and app

 

3 Patents submitted

 

Collaboration with a leading pharma  company to develop customized solution

Company Overview

ian.png

Ian Solomon

CTO

 
Picture1.png

Danny Lieberman 

CEO

4.png

Read more...


Currently there is no effective way to monitor respiratory outpatients.

Our system measures breathing patterns and volumetric changes of the lung using only a small, unobtrusive passive patch, adhered to the body, that can be used with infants to elderly people.

Remote monitoring of respiratory conditions can improve health outcomes and reduce emergency department visits, hospitalizations, length of hospital stays, and readmissions

Unlike existing devices, our remote monitoring patch can accurately detect mild, asymptomatic irregularities in breathing patterns and timely detect a major respiratory episode allowing for medical intervention and prevent ER visits and hospitalization.





Automated patient data collection and monitoring for increasing patient adherence and clinical research efficiency.

Picture2.png

Dr. Dan Peres 

CPO

Picture3.png

Eugene Kalosha

CTO

Highlights

35 clinical trials on the platform

20 customers including Philips, Theranica Therapeutics and Weizmann Institute

9M patient/device signals

3 FDA approvals

Cash-flow positive

Company Overview

 
Picture1.png

Dr. Ulrich Mühlner

Co-Founder & CEO

1.png

docdok.health is the "Netflix of Healthcare" utilizing the power of patient generated health data to ​provide tailored medical grade application and digital therapeutics (DTx).

 

Read more...


Serenus.AI is an AI-based innovative decision support tool for personalized medical treatment decisions, providing the right treatment, to the right patient at the right time. Major attributions:

  • AI-based objective personalized decision-making.
  • Comprehensive review of all relevant factors and its impact.
  • Alternative conservative recommendations.
  • Improved patient history and data flow.
  • Advanced dashboard and powerful AI-driven analytics





Picture2.png

Yves Nordmann, M.D.

Co-Founder & CMO

Picture3.png

Eitan Arat

CTO

Highlights

Internationally multi-awarded digital health company, first European startup selected for ARC partnership

Clinical work co-developed with two of the Top 10 Hospitals of the World 2020

Multiple top-notch clients and partners like Novartis, AstraZeneca, NovoNordisk, IBM and T-Systems

Active in 5 countries (CH, D, AT, IL and Q)

Company Overview

 
Picture1.png

Arik Ben Ishay

CEO

6.png

Biobeat has developed an AI-based end-to-end solution for remote patient monitoring. The core of the technology lies in Biobeat’s proprietary sensor, which is able to monitor 15 vital signs wirelessly, continuously and non-invasively.

Read more...


Serenus.AI is an AI-based innovative decision support tool for personalized medical treatment decisions, providing the right treatment, to the right patient at the right time. Major attributions:

  • AI-based objective personalized decision-making.
  • Comprehensive review of all relevant factors and its impact.
  • Alternative conservative recommendations.
  • Improved patient history and data flow.
  • Advanced dashboard and powerful AI-driven analytics





Picture2.png

Johanan May

CTO

Picture3.png

Israel Sarussi

VP R&D

Highlights

$5M in sales across the US and Europe.

Implemented in 13 Hospitals in under 4 weeks for COVID-19 monitoring

Multiple signed MSAs with the world’s biggest pharma companies and CROs

Several paid pilots and POCs lined up in the US throughout the next year.

Company Overview

 
Picture1.png

Guy Vinograd

CEO

5.png

Bio-T has developed a cloud software that enables medical device manufacturers to seamlessly convert their medical devices to IoT creating a data collection system that manages their device and provides remote care.

Read more...


Currently there is no effective way to monitor respiratory outpatients.

Our system measures breathing patterns and volumetric changes of the lung using only a small, unobtrusive passive patch, adhered to the body, that can be used with infants to elderly people.

Remote monitoring of respiratory conditions can improve health outcomes and reduce emergency department visits, hospitalizations, length of hospital stays, and readmissions

Unlike existing devices, our remote monitoring patch can accurately detect mild, asymptomatic irregularities in breathing patterns and timely detect a major respiratory episode allowing for medical intervention and prevent ER visits and hospitalization.





Picture2.png

Boaz Vaizler

COO

Picture3.png

Daniel Adler

CBO

Highlights

Completed MVP and launched with initial clients, including $Bn mkt cap companies.

Used by thousands of patients in the US market

Closely partnered with Amazon AWS

Growing pipeline with multiple Top 10 lifescience companies

Company Overview

Picture2.png

Aviv Lotan

CEO

2.png

Developing the 1st respiratory Holter, a small patch, accurately, continuously and passively monitors respiratory patients at all ages.

Read more...


Currently there is no effective way to monitor respiratory outpatients.

Our system measures breathing patterns and volumetric changes of the lung using only a small, unobtrusive passive patch, adhered to the body, that can be used with infants to elderly people.

Remote monitoring of respiratory conditions can improve health outcomes and reduce emergency department visits, hospitalizations, length of hospital stays, and readmissions

Unlike existing devices, our remote monitoring patch can accurately detect mild, asymptomatic irregularities in breathing patterns and timely detect a major respiratory episode allowing for medical intervention and prevent ER visits and hospitalization.





Picture3.png

Dr. Zvi Reznic

CTO

Picture4.png

Dr. Ari Derowe

CMO

Highlights

Successful clinical POC

Patent granted in the US

Growing interest in clinical collaboration

$1M approved funds from the Israeli Innovation Authority (to be matched)

Company Overview

 
 
Picture1.png

Hila Goldman-Aslan

CEO

9.png

DiA is the leading provider of AI-powered ultrasound analysis solutions. DiA transforms the way clinicians capture and analyze ultrasound  images.

Our vision is to leverage AI to make the use and analysis of ultrasound images smarter and accessible to all.

Read more...


TimeStamp is adding connectivity & IoT functionality to existing drug-delivery device and packages by applying our proprietary "Smart-Sticker" devices. This pioneering approach enables the incorporation of medication adherence data into everyday healthcare. Unlike competing technologies, TimeStamp’s technology, does not depend on patient engagement.





Picture2.png

Michal Yaacobi

CTO

Highlights

7 FDA and CE approved solutions

8 Channle Partners including GE Healthcare, IBM Watson Health, and Konica Minolta

Serving thousands of end-users in more than 20 countries

Company Overview